Related references
Note: Only part of the references are listed.Discovery of a Hydroxypyridinone APJ Receptor Agonist as a Clinical Candidate
James A. Johnson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Heart Failure With Reduced Ejection Fraction A Review
Sean P. Murphy et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Cardiovascular response to small-molecule APJ activation
Brandon Ason et al.
JCI INSIGHT (2020)
Heart failure with preserved ejection fraction: current management and future strategies
Carsten Tschoepe et al.
CLINICAL RESEARCH IN CARDIOLOGY (2018)
Do patients have worse outcomes in heart failure than in cancer? A primary care-based cohort study with 10-year follow-up in Scotland
Mamas A. Mamas et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Elabela/Toddler Is an Endogenous Agonist of the Apelin APJ Receptor in the Adult Cardiovascular System, and Exogenous Administration of the Peptide Compensates for the Downregulation of Its Expression in Pulmonary Arterial Hypertension
Peiran Yang et al.
CIRCULATION (2017)
Apelin-13 administration protects against ischaemia/reperfusion-mediated apoptosis through the FoxO1 pathway in high-fat diet-induced obesity
Frederic Boal et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Epidemiology and aetiology of heart failure
Boback Ziaeian et al.
NATURE REVIEWS CARDIOLOGY (2016)
Diuretic Therapy in Heart Failure - Current Approaches
Gavino Casu et al.
EUROPEAN CARDIOLOGY REVIEW (2015)
Effect of apelin on the cardiac hemodynamics in hypertensive rats with heart failure
Hui Pang et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2014)
Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
John J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Pyroglutamyl apelin-13 identified as the major apelin isoform in human plasma
Eugene Y. Zhen et al.
ANALYTICAL BIOCHEMISTRY (2013)
The Ambivalent Chemistry of a Free Anionic N-Heterocyclic Carbene Decorated with a Malonate Backbone: The Plus of a Negative Charge
Vincent Cesar et al.
CHEMISTRY-A EUROPEAN JOURNAL (2013)
Sustained Cardiovascular Actions of APJ Agonism During Renin-Angiotensin System Activation and in Patients With Heart Failure
Gareth D. Barnes et al.
CIRCULATION-HEART FAILURE (2013)
Loss of Apelin Exacerbates Myocardial Infarction Adverse Remodeling and Ischemia-reperfusion Injury: Therapeutic Potential of Synthetic Apelin Analogues
Wang Wang et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
Acute Cardiovascular Effects of Apelin in Humans Potential Role in Patients With Chronic Heart Failure
A. G. Japp et al.
CIRCULATION (2010)
Agents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyond
John R. Teerlink et al.
HEART FAILURE REVIEWS (2009)
Vascular effects of apelin in vivo in man
Alan G. Japp et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats
Pal Pacher et al.
NATURE PROTOCOLS (2008)
Impaired heart Contractility in apelin gene-deficient mice associated with aging and pressure overload
Keiji Kuba et al.
CIRCULATION RESEARCH (2007)
International Union of Pharmacology. XLVI. G protein-coupled receptor list
SM Foord et al.
PHARMACOLOGICAL REVIEWS (2005)
Immunocytochemical localisation of the apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and endothelial cells
MJ Kleinz et al.
REGULATORY PEPTIDES (2005)
The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism
K Tatemoto et al.
REGULATORY PEPTIDES (2001)
[125I]-(Pyr1)Apelin-13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man
SD Katugampola et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Share Paper
